Martínez-Aguilar MM, Juárez-Orozco LE, Jordán-Ríos A, Torres-Araujo LV, Walls-Laguarda L, Rodríguez-García JR, Casares-Echeverría LJ, Alexánderson-Rosas E

Language: Spanish
References: 16
Page: 43-49
PDF size: 264.12 Kb.

ABSTRACT

Infective endocarditis is a condition that requires an early diagnosis and treatment to prevent its severe complications and, above all, avoid death. In this article we document the diagnosis and therapeutics of a case of infective endocarditis in the setting of a congenital heart disease, bicuspid aortic valve, referred to the National Institute of Cardiology “Ignacio Chávez”.

REFERENCES

1. Fernández-Hidalgo N, Almirante B. La endocarditis infecciosa en el siglo XXI: cambios epidemiológicos, terapéuticos y pronósticos. Enferm Infecc Microbiol Clin. 2012;30:394-406.

2. Morellion P, Que Ya. Infective Endocarditis. Lancet. 2004; 363:139.

3. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis. Recommendations by the American Heart Association. Circulation. 2007;116:1736.

4. Baddour Larry M. Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management Of Complications. Circulation. 2005;111:e394-e434.

5. Sahpira O, Tadros MT, Klein MD. Ascending Aortic Dilation Associated With Bicuspid Aortic Bivalve Pathophysiologu, Molecular Biology and Clinical Implications. Circulation. 2009; 119:880-9.

6. Gersony WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993;87(2 Suppl):I121.

7. Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol. 1970;26(1):72.

8. Pérez-Lescure Picarzo J, et al. Guía clínica para la prevención de endocarditis infecciosa. An Pediatr (Barc). 2013.

9. Guadalajara JF. Cardiología. 7ma ed. Distrito Federal: Méndez editores; 2012.

10. Al-Salih G, Al-Attar N, Delbosc S, Louedec L, Corvazier E, Loyau S, et al. Role of Vegetation-Associated Protease Activity in Valve Destruction in Human Infective Endocarditis. PLOS ONE. 2012;7(9):1-11.

11. Gould FK, Denning DW, Elliott TSJ, Foweraker J, Perry JD, Prendergast BD, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2012;67:269-89.

12. Baluta MM, Benea EO, Stanescu CM, Vintila MM. Endocarditis in the 21st Century. Medica. 2011;6(4):290-7.

13. Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer WA, et al. Diagnosis and Management of Infective Endocarditis and Its Complications. Circulation. 1998;98:2936-48.

14. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis. European Heart Journal. 2004;25:267-76.

15. Sy RW, Chawantanpipat C, Richmond DR, et al. Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis. European Heart Journal. 2011;32:2016-26.

16. Kamaledeen A, Young C, Attia RQ. What are the differences in outcomes between right-sided active infective endocarditis with and without left-sided infection? Interactive CardioVascular and Thoracic Surgery. 2012;14:205-8.